by drstegallio | Jun 22, 2017 | Cancer, Cancer Research, Cancer Treatment
UTMB professor Satish Srivastava said that combining a newly-developed drug with a drug used to fight numerous kinds of cancers makes it better suited as a colon cancer treatment. The widely-used drug, doxorubicin, is effective in fighting cancer but can be toxic to...
by drstegallio | Jun 15, 2017 | Cancer, Cancer Treatment
Symptoms are common among patients receiving treatment for advanced cancers, yet are undetected by clinicians up to half the time. There is growing interest in integrating electronic patient-reported outcomes (PROs) into routine oncology practice for symptom...
by drstegallio | Jun 9, 2017 | Cancer, Cancer Treatment
“Cancer is most curable when it’s detected at its earliest stages. While it is much too soon to identify the specific cause of this positive trend, or determine whether it is sustainable and will improve outcomes, it is indeed a step in the right...
by drstegallio | Jun 7, 2017 | Cancer, Cancer Research, Cancer Treatment
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and...
by drstegallio | Jun 6, 2017 | Cancer, Cancer Research, Cancer Treatment
UCLA scientists have discovered that people with cancers containing genetic mutations JAK1 or JAK2, which are known to prevent tumors from recognizing or receiving signals from T cells to stop growing, will have little or no benefit from the immunotherapy drug...
by drstegallio | Jun 1, 2017 | Cancer, Cancer Treatment
Treating head and neck cancer patients with a twice-daily radiation therapy combined with chemotherapy could save more lives, according to new research presented at the European Cancer Congress 2017. The study, led by Dr Claire Petit, a resident in radiation oncology...
